Mali operates a three-tier healthcare system consisting of community health centers (CSCom), reference health centers (CSRéf), and regional and national hospitals. Bamako hosts the country's most equipped facilities including Hôpital du Point G, established 1906, which serves as the primary teaching hospital with approximately 400 beds, and Hôpital Gabriel Touré, the main pediatric and maternity facility with 450 beds. The private Clinique Pasteur in Bamako provides services approaching international standards with emergency departments and surgical capabilities. Outside the capital, medical infrastructure deteriorates sharply. Regional capitals like Ségou, Mopti, and Kayes have CSRéf facilities that handle basic emergencies but lack consistent diagnostic equipment, blood banks, or specialist physicians. The physician-to-population ratio stands at approximately 1 per 10,000 people as of 2022 data, concentrated overwhelmingly in Bamako where nearly 60 percent of the country's doctors practice.
Emergency medical services in Mali do not function as coordinated rapid-response systems. The SAMU (Service d'Aide Médicale Urgente) operates in Bamako with phone number 15, but response times vary from 30 minutes to several hours depending on location and traffic conditions. The fleet consists of fewer than 20 ambulances for a metropolitan population exceeding 2.8 million. Outside Bamako, formalized ambulance services are essentially absent. Medical evacuations to facilities in Dakar, Senegal or Europe become necessary for serious trauma, cardiac events, complex surgeries, or intensive care requirements. Several air ambulance companies operate charter medical flights from Bamako-Sénou International Airport, though costs typically start at 25,000 euros for European destinations. Travel insurance policies that explicitly cover medical evacuation from Mali are necessary rather than optional. The security situation in northern and central regions since 2012 has further degraded medical access, with facilities in Gao, Timbuktu, and Kidal operating intermittently or with severely reduced staff.
Pharmacies in Bamako stock basic medications including common antibiotics, antimalarials, and chronic disease treatments, though supply chains experience frequent interruptions. Counterfeit pharmaceuticals represent a documented problem, with estimates suggesting 30 to 50 percent of medications in informal markets may be substandard or falsified according to WHO assessments from 2019. Legitimate pharmacy chains include Pharmacie du Grand Marché and Pharmacie Nouvelle in Bamako, which maintain refrigeration for insulin and vaccines. Outside major cities, pharmaceutical availability becomes unpredictable. Travelers requiring specific medications should carry full supplies with original packaging and prescriptions. Refrigerated medications pose particular challenges given electrical grid unreliability and temperatures reaching 45 degrees Celsius during hot season from March through May.
Malaria represents the leading cause of medical consultation and hospitalization in Mali, accounting for approximately 35 percent of outpatient visits and 40 percent of hospital admissions according to Mali's Direction Nationale de la Santé. Transmission occurs year-round across the entire country, with peak intensity during and immediately following rainy season from June through October. The primary vectors are Anopheles gambiae and Anopheles funestus mosquitoes. Plasmodium falciparum accounts for over 95 percent of cases, with documented resistance to chloroquine and sulfadoxine-pyrimethamine. Current first-line treatment follows artemisinin-based combination therapy protocols, specifically artemether-lumefantrine. Travelers should begin prophylaxis with atovaquone-proguanil, doxycycline, or mefloquine before arrival and continue for the specified duration after departure, consulting a physician specializing in travel medicine for appropriate selection based on individual medical history.
Water and foodborne diseases constitute the second major health risk category. The national rate of access to improved drinking water sources stands at 77 percent according to 2020 UNICEF data, but only 35 percent in rural areas. Bamako's municipal water system, managed by Société Malienne de Gestion de l'Eau Potable, provides treated water to connected households, but service interruptions are routine and storage tanks frequently become contaminated. Bottled water brands including Tominé, Diago, and Djoliba are widely available in cities. All other water requires treatment through boiling for one minute, filtration with 0.1-micron pore size, or chemical disinfection. Ice should be assumed unsafe unless confirmed made from treated water. Typhoid fever, hepatitis A, and bacterial diarrhea from enterotoxigenic E. coli are endemic. Cholera outbreaks occur during rainy seasons, with notable epidemics in 2011 affecting over 3,000 cases and in 2019 with approximately 900 confirmed cases concentrated in Ségou and Mopti regions.
Meningococcal meningitis follows seasonal patterns in Mali, which lies within the African meningitis belt extending from Senegal to Ethiopia. The dry season from December through May, particularly February through April when humidity drops below 20 percent and Harmattan dust storms blow from the Sahara, creates conditions for epidemic transmission. Mali experienced major epidemics in 1997 with over 10,000 cases, 2009 with 1,350 cases, and smaller outbreaks in 2012 and 2017. Vaccination with quadrivalent conjugate vaccine covering serogroups A, C, W, and Y is required for travelers entering from endemic countries during epidemic seasons and strongly recommended for all visitors planning stays longer than one month or close contact with local populations. The vaccine should be administered at least 10 days before arrival.
Dengue fever transmission was first confirmed in Bamako in 2019, with subsequent surveillance detecting sporadic cases through 2022. Yellow fever remains endemic in Mali's southern regions bordering Guinea and Côte d'Ivoire, with most recent confirmed outbreak in 2020 involving 30 laboratory-confirmed cases in Sikasso and Koulikoro regions. Mali requires proof of yellow fever vaccination for all travelers arriving from countries with risk of yellow fever transmission. The vaccine must be recorded on an International Certificate of Vaccination with vaccination occurring at least 10 days before arrival. This is a WHO-mandated country requirement enforced at Bamako-Sénou International Airport and land borders. Travelers without valid certificates may be refused entry or vaccinated at the border under suboptimal conditions.
Rabies circulates widely in Mali's dog population, with canine rabies accounting for approximately 95 percent of human exposures. The national animal vaccination rate remains below 20 percent in most regions. Stray dogs populate every urban area, and livestock guardian dogs in rural areas may be aggressive. Bats throughout Mali should be considered potential rabies vectors. Post-exposure prophylaxis requires five doses of rabies vaccine over 28 days plus rabies immunoglobulin for previously unvaccinated individuals, administered ideally within hours of exposure. Rabies immunoglobulin is not consistently available in Mali, making pre-exposure vaccination series advisable for travelers expecting animal contact or staying beyond immediate urban centers. The three-dose pre-exposure series does not eliminate need for post-exposure vaccination but simplifies the protocol and removes need for immunoglobulin.
Tuberculosis incidence in Mali is estimated at 53 cases per 100,000 population according to 2021 WHO data, with multi-drug resistant TB representing approximately 2.5 percent of new cases. HIV prevalence stands at 1.1 percent in adults aged 15-49 based on 2020 UNAIDS estimates, concentrated in urban areas and among specific populations. Hepatitis B chronic infection rate approaches 10 percent of the population. Schistosomiasis from contact with fresh water in the Niger River, Inner Niger Delta, and irrigation canals affects an estimated 4 million Malians. The parasites Schistosoma haematobium and Schistosoma mansoni are both present. Swimming, wading, or direct contact with fresh water bodies should be avoided. Chlorinated swimming pools in hotels present low risk if properly maintained.
Blood supply safety remains compromised in Mali. The Centre National de Transfusion Sanguine in Bamako tests donated blood for HIV, hepatitis B, hepatitis C, and syphilis, but blood banks in regional centers may lack consistent screening capacity. Blood products should be refused except in life-threatening emergencies, and only from facilities confirming all screening protocols. Travelers with rare blood types or anticipating high-risk activities should investigate medical evacuation insurance provisions for emergency blood transport.